Multi-center, randomized, comparator-controlled, single-blind, parallel-group study to investigate the pharmacodynamics, pharmacokinetics and safety of an intrauterine system releasing BAY 1007626, as compared with Mirena and Jaydess, in a combined proof-of-concept and dose-finding study in healthy pre menopausal women treated for 90 days

Trial Profile

Multi-center, randomized, comparator-controlled, single-blind, parallel-group study to investigate the pharmacodynamics, pharmacokinetics and safety of an intrauterine system releasing BAY 1007626, as compared with Mirena and Jaydess, in a combined proof-of-concept and dose-finding study in healthy pre menopausal women treated for 90 days

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Jul 2017

At a glance

  • Drugs BAY 1007626 (Primary) ; Levonorgestrel
  • Indications Pregnancy
  • Focus Pharmacodynamics; Proof of concept; Therapeutic Use
  • Sponsors Bayer HealthCare
  • Most Recent Events

    • 29 Mar 2017 This trial has been discontinued in UK (End date:2016-05-26), according to European Clinical Trials Database.
    • 27 Jul 2016 Status changed from suspended to completed.
    • 14 Jul 2016 This trial was discontinued in Netherlands, according to European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top